Farvatn Venture

Oivi is a company that specializes in developing an affordable AI-powered camera and platform for identifying diabetic eye diseases. Founded in 2017 and headquartered in Oslo, Norway, Oivi's technology enables retinal screening in primary care settings, helping to raise awareness and support the maintenance of eye health for individuals with diabetes. The platform features automated image capture and diagnostics, allowing for effective monitoring of eye conditions through teleconsultation. With a diverse team skilled in camera and software development, Oivi aims to facilitate early detection and prevention of diabetes-related vision loss, ultimately contributing to improved patient outcomes.

Link Venture Capital is a venture capital investment firm established in 2017 and based in Stavanger, Norway. The firm specializes in early-stage investments, focusing on sectors such as technology, clean energy, software, aquaculture, electric vehicles, and the sustainable economy. It aims to support companies in the European and Nordic regions that are innovating in mobility and deep tech, as well as those contributing to the energy transition. By investing in these areas, Link Venture Capital seeks to foster growth and development in industries that are pivotal for a sustainable future.

Geniess is an energy-tech company based in Oslo, Norway, focused on facilitating clean electrification through enhanced distributed energy storage. Founded in 2021, the company offers a software platform that assists battery storage system developers in identifying suitable customers and optimizing the configuration of battery installations. This platform enables energy storage sellers and buyers to validate installations, scope robust systems, and assess potential returns on investment. By improving decision-making processes, Geniess helps battery developers increase profitability and accelerate their business growth.

Evoy is a Norwegian manufacturer of electric propulsion systems, established in 2018 and located in Florø, Sogn og Fjordane. The company specializes in producing inboard and outboard electric motors designed to replace traditional diesel and gasoline systems in speedboats. By doing so, Evoy enables boat owners to significantly reduce maintenance and operational costs while eliminating noise, smell, and pollution associated with conventional engines. The electric motors are engineered to provide strong performance and responsiveness, catering to the needs of ferry and tour operators who aim to meet sustainability goals and comply with environmental regulations.

Cimon Medical AS, based in Trondheim, Norway, specializes in the development and manufacturing of ultrasound blood-flow monitoring devices. Founded in 2019, the company has created the NeoDoppler device, which allows for direct, non-invasive, and continuous monitoring of blood flow in the brains of premature or critically ill infants. The core innovation lies in a coin-sized ultrasound probe that operates as a single-element transducer with an unfocused beam, enabling the continuous measurement of blood circulation by illuminating a 1×4 cm cylindrical area of tissue. This design allows for the simultaneous capture of all blood flow signals within that volume, providing valuable relative measures of blood volume flow without the need for complex equipment or highly skilled operators. Cimon Medical's technology addresses previous challenges in continuous blood flow monitoring, offering a simpler and more efficient solution for healthcare providers.

Shifter is an independent news site focused on the Norwegian technology sector, covering both startups and innovations within larger companies. It aims to provide valuable insights into the dynamics of the tech industry, highlighting ideas, challenges, and stories that shape the new economy. The publication is staffed by experienced reporters Lucas H. Weldeghebriel and Per-Ivar Nikolaisen, who have backgrounds in prominent Norwegian media outlets. Shifter's platform is dedicated to delivering informative articles and updates, ensuring that readers stay informed about the evolving landscape of technology startups in Norway.

Serendipity Partners was established to secure a dedicated source of capital to invest in the healthcare area, leveraging successful long-term experience in company management and sector expertise. The fund will invest in companies that conduct the majority of their business or otherwise have a principal connection to Europe. The fund will have a special emphasis on the Nordics (Norway, Sweden, Finland, Denmark, and Island). The remainder Northern European countries will also be a focus area. The fund has established a well-connected network of senior healthcare professionals, covering several European countries that will help to source deals in a proprietary manner. The Fund is registered by The Financial Supervisory Authority of Norway and has approximately NOK 800 mill under management. The Healthcare fund will acquire controlling positions, but also non-majority positions in which the business can be influenced in a value creating manner (e.g., board representation or similar positions, shareholder agreements or similar agreements). The main focus of the fund will be mature cash flow positive companies, but the fund may invest up to 20% in earlier stage companies. Half of the investments can be in public companies. The fund will target companies within a number of healthcare sectors, including pharmaceutical/nutraceuticals, diagnostics, novel products for lowering of health care spending, medical devices, and healthcare providers. Deals are evaluated through a well-tested Private Equity framework. We seek to become partners with public and family business owners, management teams, and excellent CEOs who have as their goal significant long-term growth in their enterprise. We believe that we have assembled the culture, philosophy, tools, knowledge and skills necessary to support this growth-journey.

Norselab AS is a venture capital investment firm and incubator based in Oslo, Norway, with additional offices in Palo Alto, California, and Odessa, Ukraine. Founded in 2015, Norselab specializes in investing in startups and growth companies within the technology sector, particularly focusing on data-centric industries, business intelligence, online marketplaces, software as a service, and the Internet of Things. The firm typically makes investments ranging from 2.83 million to 5.67 million and targets companies in Series A and later stages. Norselab is committed to supporting net-positive companies that aim to drive meaningful change in resource-intensive global industries, reflecting its dedication to impact-driven investment.

Hadean Ventures is a venture capital firm based in Oslo, Norway, established in 2014. It specializes in investing in life science and healthcare companies throughout Europe, with a particular emphasis on the Nordic region. The firm collaborates with leading academic institutions and startup hubs, leveraging these partnerships to identify and support innovative healthcare solutions. Hadean Ventures is backed by prominent private and institutional investors, enabling it to pursue a diverse range of investment opportunities across various stages and verticals within the healthcare sector.

Ocean Oasis is a water company that develops a new and sustainable way of producing fresh water using wave power. The company's solution is an environmentally friendly, flexible, and robust desalination platform driven by wave power that can deliver fresh water to shore at a competitive cost. Ocean Oasis utilizes the power of waves to deliver desalinated water to shore where needed in a flexible, efficient way and without emissions, through putting Norway’s unique offshore competence to work. The company was founded in 2020 and is based in Oslo, Norway.